TrialUrologic oncology2018
Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial.
Jonathan Gelfond et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it